Outset Medical Inc
Statements
Cash Flow
Outset Medical Inc (OM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -9.6 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -18 | -20 | -17 | -15 | -25 | -19 | -29 | -26 | -39 | -31 | -28 | -33 | -38 | -39 | -34 | -34 | -45 | -28 | -34 | -24 | -46 | -33 | -21 | -16 | -26 | -4.8 | -6.3 | -9.5 | -13 | -9.6 | -38 | |
| 0.5 | 0.5 | 0.1 | 0.8 | 0.3 | 0.4 | 0.8 | 1.9 | 1.2 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.6 | 1.4 | 1.5 | 1.5 | 1.4 | 1.5 | 1.5 | -2.5 | 1.4 | 1.3 | 1.2 | 0.3 | 0.9 | 0.4 | 1.0 | 2.6 | |
| 0.2 | 0.2 | 0.2 | 0.2 | 0.6 | 0.7 | 14 | 6.3 | 5.9 | 3.9 | 2.9 | 4.8 | 5.0 | 7.4 | 7.4 | 7.4 | 8.5 | 10 | 11 | 9.1 | 8.2 | 9.8 | 6.4 | 4.9 | 3.0 | 3.5 | 5.1 | 4.1 | 3.5 | 2.7 | 15 | |
| -0.5 | 0.3 | -2.4 | – | 0.6 | 1.6 | 16 | 7.0 | -8.6 | 4.9 | -18 | -14 | 5.6 | -2.8 | 8.4 | 9.7 | 9.9 | 9.3 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -4.3 | -1.4 | 1.5 | 3.2 | -5.3 | 5.0 | -2.9 | -2.7 | -16 | -6.9 | -3.4 | 0.9 | -9.3 | -4.6 | -3.6 | -3.7 | -11 | 5.1 | 0.9 | 4.0 | -15 | -12 | -0.4 | 2.1 | -13 | 7.3 | 6.0 | 1.5 | 1.5 | 3.2 | 12 | |
| 1.1 | 1.3 | 0.5 | 0.5 | 2.8 | 2.2 | 1.5 | 2.7 | 0.9 | 0.8 | 0.5 | 0.9 | 1.5 | 2.0 | 2.7 | 2.1 | 0.8 | 0.8 | 0.8 | 1.1 | 0.4 | 0.1 | 0.4 | 0.0 | 0.1 | 0.3 | 0.2 | 0.2 | 0.1 | 0.1 | 0.6 | |
| 9.2 | 7.6 | 45 | 13 | 19 | 6.3 | -32 | 10 | -6.8 | -97 | -22 | -16 | -33 | -1.3 | 20 | -52 | 2.6 | 27 | 30 | 23 | -59 | 39 | 16 | 108 | -78 | -31 | 3.0 | 8.6 | 7.9 | 14 | 34 | |
| – | – | – | – | – | – | – | -0.9 | – | 149 | – | – | – | – | – | – | – | – | – | – | – | -2.1 | 2.1 | – | – | – | – | – | – | – | – | |
| 0.0 | 0.0 | 0.0 | – | 0.0 | 0.0 | -1.4 | 0.0 | – | – | – | – | – | – | 65 | 96 | – | – | – | – | – | – | 0.0 | 0.0 | -107 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | -0.1 | |
| 0.1 | 0.2 | -0.2 | 0.1 | 127 | 0.0 | 260 | -0.9 | 2.2 | 151 | 6.2 | 0.9 | 3.7 | 1.0 | 2.5 | 65 | 5.3 | 1.0 | 4.1 | 33 | 69 | 0.1 | 0.1 | -0.9 | 56 | -0.4 | 0.2 | 0.0 | 0.5 | -0.1 | 0.6 | |
| -9.0 | -12 | 28 | -2.3 | 121 | -13 | 169 | -16 | -43 | 23 | -44 | -48 | -68 | -39 | -12 | 9.3 | -37 | 0.0 | -0.1 | 32 | -36 | 5.7 | -4.6 | 91 | -48 | -36 | -3.1 | -0.9 | -4.4 | 4.4 | -4.1 | |
| -19 | -21 | -17 | -16 | -28 | -21 | -31 | -29 | -40 | -32 | -29 | -34 | -40 | -41 | -37 | -36 | -46 | -29 | -35 | -25 | -46 | -33 | -21 | -17 | -26 | -5.1 | -6.5 | -9.7 | -13 | -9.7 | -39 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.